Skip to main content

GalNAc-L96 - A Key Molecule for Efficient RNA Targeted Delivery

Introduction to GalNAc-L96

GalNAc-L96 (CAS 1159408-62-4) is a triantennary N-acetylgalactosamine (GalNAc) ligand primarily used for the synthesis of GalNAc-siRNA. GalNAc is a specific ligand for ASGPR (Asialoglycoprotein Receptor), enabling liver-targeted delivery, which is a crucial aspect of modern RNA delivery technology.

Applications and Advantages of GalNAc-L96

  1. Precise Liver-Targeted Delivery: ASGPR is highly expressed on liver cell surfaces, allowing siRNA, antisense oligonucleotides (ASO), or other nucleic acid drugs conjugated with GalNAc-L96 to efficiently enter liver cells and enhance therapeutic effects.
  2. Enhanced Bioavailability of siRNA: Traditional siRNA delivery methods (such as lipid nanoparticles, LNPs) often lead to non-specific distribution, whereas GalNAc-conjugated siRNA (GalNAc-siRNA) enables more efficient and safer RNA interference (RNAi) therapy.
  3. Reduced Systemic Toxicity: Due to the high specificity of GalNAc delivery, compared to LNPs, GalNAc-siRNA exhibits lower immunogenicity and reduced side effects, making it a preferred strategy for RNA drug development.
  4. Improved Stability and Optimized Pharmacokinetics: By optimizing the structure of GalNAc-L96, its affinity for ASGPR can be enhanced, thereby increasing hepatic cell uptake and prolonging in vivo half-life.

Watson’s Unique Advantages in the GalNAc Field

  1. Advanced Synthesis Techniques and Purity Control
  • Watson leverages cutting-edge glycochemistry and nucleic acid modification technologies to provide high-purity, high-quality GalNAc-L96 and its derivatives, ensuring optimal outcomes in RNAi and ASO drug development.
  1. Comprehensive Support from Lab to Industrial Scale
  • Watson not only supplies small-scale research-grade products but also has pilot and industrial-scale production capabilities, meeting the demands from early-stage research to clinical production.
  • Strict adherence to quality management systems (ISO certification) ensures product quality and stability.
  1. Strong Technical Expertise and Industry Recognition
  • With years of experience in glycoconjugates and RNA delivery, Watson collaborates with leading pharmaceutical and biotechnology companies worldwide, driving advancements in RNA therapeutics.
  • Watson’s high-end customization and innovative synthesis capabilities make it a key global partner in RNA delivery technologies.

Conclusion

As a core ligand for RNA-targeted delivery, GalNAc-L96 plays a vital role in siRNA and ASO therapies. With cutting-edge synthesis technologies, strict quality control, and strong customization capabilities, Watson holds a distinct competitive advantage in this field, supporting breakthroughs in RNA delivery technology.

If you are interested in GalNAc-related products or RNA delivery solutions, feel free to contact Watson for more information!

Reference

GalNAc-L96 on Watson International

Comments

Popular posts from this blog

BCB (Benzocyclobutene): — Watson International Enables the Transition from Concept to Scalable Application

Benzocyclobutene (BCB) is an organic compound with a rigid molecular structure composed of a conjugated benzene ring and a four-membered ring. Its excellent thermal stability and electrical properties have made it a highly promising candidate for next-generation electronic materials. Historically, its industrial adoption has been constrained by high production costs, complex purification processes, and limited output. However, with growing demand in high-end applications and recent advances in upstream technology, BCB is now poised for industrial-scale deployment. Material Properties and Structural Advantages BCB (C₈H₈) is a non-polar molecule, free of ester, carboxyl, or amide groups, giving it excellent dielectric properties and low moisture absorption. Its dielectric constant (Dk) and dissipation factor (Df) remain stable across wide temperature and frequency ranges—key metrics for ensuring signal integrity in high-frequency, high-speed communication systems. Unlike conventional m...

BCB (Benzocyclobutene): — Watson International Enables the Transition from Concept to Scalable Application

Despite BCB’s well-established performance advantages, its commercialization has long been hindered by production cost and scalability challenges. Watson International has made critical breakthroughs in BCB industrialization through integrated innovation in synthesis, purification, and material formulation: Cost Reduction: By optimizing synthetic pathways and improving by-product recovery, Watson has significantly reduced the unit production cost of BCB, enabling cost-effective scaling; High Purity Production: Advanced purification and process control technologies ensure high-purity BCB under mass-production conditions—meeting stringent requirements from high-end electronic manufacturers; Versatile Co-polymerization: Watson’s BCB materials are compatible with other advanced resins such as BMI and PPO, allowing for custom co-polymer design and performance tuning.

The World's Largest Producer of Squaric Acid Emerges: Watson Leads the Way

In a groundbreaking development for the chemical industry, Watson has officially claimed the title of the world’s largest producer of squaric acid. This achievement marks a significant milestone, positioning the company as a global leader in the production of this highly versatile compound, widely valued in pharmaceuticals, polymer research, and advanced materials. What is Squaric Acid? Squaric acid, also known as quadratic acid, is a four-carbon cyclic diketone with two ketone groups and two hydroxyl groups arranged symmetrically. It is renowned for its stability and strong acidity, making it a unique compound in both organic and inorganic chemistry. Its derivatives find applications in creating advanced coatings, conductive polymers, and as intermediates in drug synthesis. Watson: Redefining Excellence in Squaric Acid Production Watson’s rise to the top of the squaric acid industry is backed by its unmatched production capacity, cutting-edge technology, and unwavering commitment...